OCGN · Ocugen, Inc.
$1.30
-0.01 (-0.76%)
At close · Aug 5
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these factors, together with the anticipated continued spending that will be necessary to continue to research, develop, and commercialize the Company's product candidates, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued.”View the 10-Q filed May 8, 2026
Market Cap
$423.15M
Shares
338.52M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding OCGN
32 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 9,801,994 | $17,741,609 | 0.00% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 5,222,819 | $9,453,302 | 0.13% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 3,665,453 | $6,634,470 | 0.01% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | — | 2,554,326 | $4,623,330 | 0.20% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 1,704,694 | $2,352,478 | 0.01% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 931,671 | $1,285,706 | 0.01% | Long | 2026-05-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 645,821 | $1,168,936 | 0.00% | Long | 2026-03-31 | |
| iShares Genomics Immunology and Healthcare ETF | — | 548,690 | $949,234 | 0.59% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 603,719 | $833,132 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 501,236 | $691,706 | 0.00% | Long | 2026-05-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 304,496 | $526,778 | 0.10% | Long | 2026-04-30 | |
| Schwab Total Stock Market Index Fund | — | 210,254 | $363,739 | 0.00% | Long | 2026-04-30 | |
| VANGUARD BALANCED INDEX FUND | — | 187,541 | $339,449 | 0.00% | Long | 2026-03-31 | |
| Fidelity ZERO Total Market Index Fund | — | 175,442 | $303,515 | 0.00% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 194,166 | $267,949 | 0.00% | Long | 2026-05-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 146,991 | $266,054 | 0.00% | Long | 2026-03-31 | |
| Fidelity ZERO Extended Market Index Fund | — | 114,536 | $198,147 | 0.01% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index ETF | — | 132,226 | $182,472 | 0.00% | Long | 2026-05-31 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 94,238 | $163,032 | 0.09% | Long | 2026-04-30 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 78,538 | $142,154 | 0.00% | Long | 2026-03-31 | |
| Goldman Sachs Innovate Equity ETF | — | 63,363 | $87,441 | 0.04% | Long | 2026-05-31 | |
| Fidelity Flex Small Cap Index Fund | — | 49,386 | $85,438 | 0.02% | Long | 2026-04-30 | |
| Victory Extended Market Index Fund | — | 36,556 | $63,242 | 0.01% | Long | 2026-04-30 | |
| PROFUND VP BIOTECHNOLOGY | — | 29,074 | $52,624 | 0.13% | Long | 2026-03-31 | |
| VIP Extended Market Index Portfolio | — | 22,064 | $39,936 | 0.01% | Long | 2026-03-31 | |
| VIP Total Market Index Portfolio | — | 7,448 | $13,481 | 0.00% | Long | 2026-03-31 | |
| Total Stock Market Index Trust | — | 5,289 | $9,573 | 0.00% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 4,900 | $8,869 | 0.00% | Long | 2026-03-31 | |
| State Street Balanced Index Fund | — | 3,448 | $6,241 | 0.00% | Long | 2026-03-31 | |
| Guggenheim Active Allocation Fund | GUG | 2,201 | $3,037 | 0.00% | Long | 2026-05-29 | |
| BlackRock Small Cap Index V.I. Fund | — | 1,394 | $2,523 | 0.00% | Long | 2026-03-31 | |
| BlackRock Small Cap Index V.I. Fund | — | 1,394 | $2,523 | 0.00% | Short | 2026-03-31 |
Showing 1–32 of 32 positions
Key facts
CIK
1372299
CUSIP
67577C105
13F (30d)
34 filings
34 filers
Visit website
Investor relations